Can-Fite BioPharma Ltd. (CANF): Shareholders' Equity
$5.59M
As of 2025-12-31
+7.7%
3-year compound annual growth
-1.6%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.59M | +2.9% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $5.44M | -12.9% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $6.24M | +39.6% | 2026-03-26, Balance as of period end |
| 2022-12-31 | $4.47M | -68.9% | 2025-04-14, Balance as of period end |
| 2021-12-31 | $14.38M | +136.8% | 2024-03-28, Balance as of period end |
| 2020-12-31 | $6.07M | +148.7% | 2023-03-30, Balance as of period end |
| 2019-12-31 | $2.44M | -19.0% | 2022-03-24, Balance as of period end |
| 2018-12-31 | $3.02M | n/a | 2021-03-25, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $5.59M | +2.9% |
| Medicinova Inc (MNOV) | 2025-12-31 | $41.59M | -20.8% |
| America Great Health (AAGH) | 2025-06-30 | -$5.66M | n/m |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $70.12M | -11.3% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$6.30M | n/m |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $40.92M | -32.9% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $9.83M | -16.8% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $3.76M | n/m |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $1.92M | -39.0% |
Compare CANF, MNOV, AAGH, SCNX side by side · Screen every company in Pharmaceutical Preparations ↗